Purpose: Prospective evaluation of the diagnostic outcome of plain and sign
al-enhanced color Doppler sonography for the differentiation between benign
and malignant cutis-involving lesions. Materials and Methods: 39 patients
with 40 suspected malignant skin lesions received an preoperative ultrasoun
d examination before and after application of 4 g Levovist(R) i.v. Spectral
Doppler, conventional color and power Doppler were performed. The images w
ere analyzed semiquantitatively using a specially developed software. The d
iagnoses were confirmed by histological analysis (37 cases) or by follow up
controls (3 cases). Results: Whereas the B-mode criteria such as echogenoi
ty, borderline and homogenecity, and the spectral Doppler analysis were not
useful for differentiation between malignant and benign lesions, the analy
sis of the intratumorously visible number of vessels and of the ratio of th
e vascularized area using a special software, especially after injection of
the signal enhancing agent, provided valuable information. In 10 of 18 ben
ign but only in 1 of 22 malignant lesions, no intratumorous vessels were vi
sible after application of Levovist (plain: 10/18 benign and 6/22 malignant
lesions). The number of visible vessels increased strongly after signal en
hancement. Using a "ratio of the vascularized area (percentage vessel area)
> 5 %" as a criterion of malignancy, 2 false positive and 2 false negative
results were observed after application of Levovist(R) (without/with Levov
ist(R) sensitivity 73 %/91 %, specificity 89 %/89 %). Conclusions: The sign
al-enhanced color Doppler sonography provides useful additional information
for the differentiation between benign and malignant cutis-involving lesio
ns, especially the semiquantitative vascularization analysis. The latter is
superior to B-mode ultrasound and to spectral Doppler analysis. The signal
enhancer increases the sensitivity, whereas the specificity remains unchan
ged.